Planned site will encompass 210,000 sq. ft. and employ 200 scientists focused on cancer and fertility.

Merck Serono and U.S. affiliate, EMD Serono, are shelling out $50 million to expand the Billerica facility outside of Boston, MA. Construction will begin early next year and is expected to be complete in 2010.

The companies plan on a 210,000 sq. ft. center of excellence in discovery, which will include more than 160,000 sq. ft. of lab space.  The new site will accommodate approximately 250 scientists. About 50 employees will be involved in process development and protein production. The rest will focus on cancer- and fertility-related R&D.

EMD also has a protein-production plant at Billerica and believes that its proximity to the planned site will help collaborations and the transition from research to manufacturing.

Previous articleAmerican Oriental Bioengineering Gains Part Ownership in China Aoxing with $18M Equity
Next articlemiRNAs AND CANCER